4.8 Article

Estrogen receptor β deficiency impairs gut microbiota: a possible mechanism of IBD-induced anxiety-like behavior

期刊

MICROBIOME
卷 10, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s40168-022-01356-2

关键词

Anxiety; ErbB4; Estrogen receptor beta; Gut microbiota; Hypothalamic-pituitary-adrenal axis; Inflammatory bowel disease; Stress

资金

  1. National Key R&D Program of China [2017YFE0103700]
  2. National Nature Science Foundation of China [31871043]
  3. Natural Science Foundation Project of Chongqing [cstc2020jcyj-msxmX0816]

向作者/读者索取更多资源

The gut microbiota plays a critical role in mediating the development of colitis and anxiety-like behaviors. Lack of ER beta leads to changes in the gut microbiota composition, exacerbating colitis and anxiety-like behaviors. Remodeling of the gut microbiota can inhibit the development of colitis and anxiety-like behaviors.
Background: Although the lack of estrogen receptor beta (ER beta) is a risk factor for the development of inflammatory bowel disease (IBD) and psychiatric disorders, the underlying cellular and molecular mechanisms are not fully understood. Herein, we revealed the role of gut microbiota in the development of IBD and related anxiety-like behavior in ER beta-deficient mice. Results: In response to dextran sodium sulfate (DSS) insult, the ER beta knockout mice displayed significant shift in alpha and beta diversity in the fecal microbiota composition and demonstrated worsening of colitis and anxiety-like behaviors. In addition, DSS-induced colitis also induced hypothalamic-pituitary-adrenal (HPA) axis hyperactivity in ER beta-deficient mice, which was associated with colitis and anxiety-like behaviors. In addition, RNA sequencing data suggested that ErbB4 might be the target of ER beta that is involved in regulating the HPA axis hyperactivity caused by DSS insult. Gut microbiota remodeling by co-housing showed that both the colitis and anxiety-like behaviors were aggravated in co-housed wild-type mice compared to single-housed wild-type mice. These findings suggest that gut microbiota play a critical role in mediating colitis disease activity and anxiety-like behaviors via aberrant neural processing within the gut-brain axis. Conclusions: ER beta has the potential to inhibit colitis development and anxiety-like behaviors via remodeling of the gut microbiota, which suggests that ER beta is a promising therapeutic target for the treatment of IBD and related anxiety-like behaviors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据